1. Home
  2. UNCY vs GGZ Comparison

UNCY vs GGZ Comparison

Compare UNCY & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.63

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Logo Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest

GGZ

Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest

HOLD

Current Price

$15.95

Market Cap

129.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNCY
GGZ
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
145.3M
129.8M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
UNCY
GGZ
Price
$6.63
$15.95
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$38.00
N/A
AVG Volume (30 Days)
489.9K
9.5K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$675,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$407.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$11.19
52 Week High
$7.57
$16.80

Technical Indicators

Market Signals
Indicator
UNCY
GGZ
Relative Strength Index (RSI) 49.09 60.69
Support Level $6.48 $15.40
Resistance Level $7.12 $16.62
Average True Range (ATR) 0.42 0.29
MACD -0.01 0.13
Stochastic Oscillator 41.22 83.86

Price Performance

Historical Comparison
UNCY
GGZ

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest

The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.

Share on Social Networks: